Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration-Reference-Cited by-同舟云学术

Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration

Published:2014-04 Issue:4 Volume:121 Page:936-945
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Stein Joshua D.,Newman-Casey Paula Anne,Mrinalini Tavag,Lee Paul P.,Hutton David W.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference54 articles.

1. National Advisory Eye Council. Vision Research, a National Plan, 1994-1998. Washington, DC: US Department of Health and Human Services; 1993. NIH publication 93–3186.

2. Prevalence of age-related macular degeneration in the United States;Arch Ophthalmol,2004

3. Prevalence of age-related maculopathy: the Beaver Dam Eye Study;Klein;Ophthalmology,1992

4. Impact of age related macular degeneration on quality of life;Hassell;Br J Ophthalmol,2006

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indications and Outcome of Intravitreal Bevacizumab Injection in a Community Eye Hospital, Nepal;2024-08-01

2. Trends in Anti-Vascular Endothelial Growth Factor Original Medicare Part B Claims in the United States, 2014–2019;Ophthalmic Epidemiology;2024-02-05

3. Cost-Utility of Rhegmatogenous Retinal Detachment Repair With Pars Plana Vitrectomy, Scleral Buckle, and Pneumatic Retinopexy: A Microsimulation Model;American Journal of Ophthalmology;2023-11

4. Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis;Medical Decision Making;2023-09-12

5. Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment;International Journal of Molecular Sciences;2023-08-21